Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2005
11/17/2005WO2005108555A2 Synthetic medium for the culture and/or freezing and/or preservation and/or transfer of embryos or cells
11/17/2005WO2005108554A1 Adoptive immunocyte for tumor vaccine and the like
11/17/2005WO2005108551A1 Osteoclast culture vessels and methods of use
11/17/2005WO2005108547A1 Patterned cell network substrate interface and methods and uses thereof
11/17/2005WO2005108428A2 Cd40 splice variants and their uses
11/17/2005WO2005107817A2 Medical device with coating for capturing genetically-altered cells and methods of using same
11/17/2005WO2005107807A2 Cerebral intraventricular transplantation as method of treating amyotrophic lateral sclerosis
11/17/2005WO2005107800A1 Monoclonal antibodies to hepatocyte growth factor
11/17/2005WO2005107796A2 Cellular permissivity factor for viruses, and uses thereof
11/17/2005WO2005107651A2 Cell permeable structural implant
11/17/2005WO2005085420A3 Leukocyte stimulation matrix
11/17/2005WO2005060553A3 Geraniol synthase, methods of production and uses thereof
11/17/2005WO2005060396A3 Nanotopographic compositions and methods for cellular organization in tissue engineered structures
11/17/2005WO2005049063A3 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
11/17/2005WO2005039643A3 In vivo gene therapy of parkinson's disease
11/17/2005WO2005021577A3 Novel plant glycine and histidinie-rich metal-binding protein family and uses thereof
11/17/2005WO2004108945A3 Oligonucleotide modulation of cell adhesion
11/17/2005WO2004078140A3 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
11/17/2005WO2003042399A8 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
11/17/2005WO2001072768A8 Single chain class i major histo-compatibility complexes, constructs encoding same and methods of generating same
11/17/2005US20050257296 Hammer cotton cultivar plant and seed
11/17/2005US20050257292 Ehd1gene promoting plant flowering, and utlization thereof
11/17/2005US20050257286 DNA sequence for root preferred gene expression in plants
11/17/2005US20050257285 Compositions and methods for the treatment of Pierce's disease
11/17/2005US20050257283 Transformed plants with enhanced prenylquinone biosynthesis
11/17/2005US20050257282 Plant centromere compositions
11/17/2005US20050257279 Agouti-related protein deficient cells, non-human transgenic animals and methods of selecting compounds which regulate energy metabolism
11/17/2005US20050257278 Transgenic non-human animals expressing a truncated activin type II receptor
11/17/2005US20050256588 Decellularized tissue
11/17/2005US20050256303 Having antibacterial activity, antioxidative effect, inflammation inhibitory effect, in vivo substance transporting action, and enzymatic activity, used as a drug administration carrier
11/17/2005US20050256299 Vaccines
11/17/2005US20050256077 Gastrointestinal stem cells and uses thereof
11/17/2005US20050256051 Nuclear receptor-mediated introduction of a PNA into cell nuclei
11/17/2005US20050256049 Chimeric toxins for targeted therapy
11/17/2005US20050256033 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
11/17/2005US20050255597 Transformation of cells with vector carrying transgenic virus
11/17/2005US20050255596 Methods of repairing tandemly repeated DNA sequences and extending cell life-span nuclear transfer
11/17/2005US20050255595 Genetically modified non-human mammal cells, procedure for their production and use in toxicity tests
11/17/2005US20050255594 Patterning substrate and cell culture substrate
11/17/2005US20050255593 Bone marrow stromal cell-derived schwann cells
11/17/2005US20050255592 Multi-lineage progenitor cells
11/17/2005US20050255591 Transplanting human hepatocytes into a liver of an immunodeficient hepatopathy mouse, feeding the mouse transplanted under such a condition as being protected from the attack by human complement produced by the human hepatocytes thereby proliferating the transplanted human hepatocytes in the mouse liver
11/17/2005US20050255590 Methods for generating neuronal cells from human embryonic stem cells and uses thereof
11/17/2005US20050255589 Generation of neural stem cells from undifferentiated human embryonic stem cells
11/17/2005US20050255588 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
11/17/2005US20050255573 An in vitro method of maintaining a mouse or human pluripotent cell in a pluripotent state by increasing expression of a gene that encodes a factor which acts intracellularly and maintainspluripotency, where the factor is a polypeptide of the sequence of SEQ ID NO: 4; cultures
11/17/2005US20050255571 Biocatalysts in chemical reactions, activity, stability and enantioselectivity; for the preparation of optically active compounds
11/17/2005US20050255569 Method for producing triterpene composition
11/17/2005US20050255559 Isolated nucleic acid molecule(s) encoding a human calcium sensitive potassium channel subunit protein designated beta2, encoded proteins, and uses thereof
11/17/2005US20050255558 Signal sequence polypeptides for diagnosis, prevention and treatment of metabolic disorders
11/17/2005US20050255557 Novel compounds
11/17/2005US20050255552 Antibody specificity transfer using minimal essential binding determinants
11/17/2005US20050255550 Suppression of xenotransplant rejection
11/17/2005US20050255549 IRAK-4: compositions and methods of use
11/17/2005US20050255546 DNA coding for a polypeptide; a polymer conjugated drug with increased stability of the protein in vivo; stimulating the production of erythrocyte progenitor cells in culture in the presence of the polypeptide, or in vivo
11/17/2005US20050255532 Antibodies that immunospecifically bind to B lymphocyte stimulator
11/17/2005US20050255531 Signal transduction
11/17/2005US20050255530 Identification and isolation of pluripotency determining factors
11/17/2005US20050255518 Methods and compositions for the treatment and diagnosis of pain disorders using 46566
11/17/2005US20050255480 A norovirus-permissive cell culture, including dendritic- and macrophage-lineage cells and macrophages having a deficiency in a cellular anti-viral pathway such as a STAT-1-dependent pathway, an interferon receptor-dependent pathway, or a PKR-dependent pathway infected with a norovirus
11/17/2005US20050255469 Human 5-ht7 receptor promoter sequence
11/17/2005US20050255125 Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine
11/17/2005US20050255113 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders
11/17/2005US20050255102 binds to alpha v beta 6 and not other alpha v integrins or non-specific integrins; inhibits the binding of alpha v beta 6 to latency associated peptide with an IC50 value lower than that of 10D5 and binds alpha v beta 6 in manner that does not distinguish between the use of Ca2+/Mg2+ and Mn2+ for cation
11/17/2005US20050255099 Antigenic fusion protein carrying Galalpha 1,3Gal epitopes
11/17/2005US20050255093 treating nervous system disorders induced by stroke or injury, injured by trauma to reduce oxidative stress, administering a conjugate of antioxidant enzyme and a clostridial neurotoxin cell binding domain, and a clostridial neurotoxin translocation domain; tissue-targeted therapy
11/17/2005US20050255087 Adeno-associated virus vectors
11/17/2005US20050255086 Adeno-associated viral vector comprising short interfering RNA for use in the treatment of nervous system disorders; tissue engineering and gene therapy; tissue targeted therapy
11/17/2005US20050255084 Use of a half-transporter protein of the abcg-family for selecting cells and in gene therapy
11/17/2005US20050255041 Administering monoclonal antibody or antigen binding fragment accession number 270404-01; primary and metastatic tumors
11/17/2005US20050253292 Method for forming scaffolds
11/17/2005US20050252867 preparing a completely autologous bioadhesive sealant composition; all the blood components come from the patient to whom the sealant will be used
11/17/2005CA2566549A1 A method for isolating mammary stem cells
11/17/2005CA2566344A1 Mutant pneumolysin proteins
11/17/2005CA2565858A1 Assay for drug discovery based on in vitro differentiated cells
11/17/2005CA2565855A1 Patterned cell network substrate interface and methods and uses thereof
11/17/2005CA2564769A1 Cellular permissivity factor for viruses, and uses thereof
11/17/2005CA2564552A1 Osteoclast culture vessels and methods of use
11/17/2005CA2564039A1 Methods for assembling multiple expression constructs
11/17/2005CA2563521A1 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
11/17/2005CA2563518A1 Multi-lineage progenitor cells
11/17/2005CA2563329A1 Medical device with coating for capturing genetically-altered cells and methods of using same
11/17/2005CA2563080A1 Monoclonal antibodies to hepatocyte growth factor
11/17/2005CA2560264A1 Gm1 promoter and use thereof
11/17/2005CA2540969A1 Cell permeable structural implant
11/16/2005EP1595955A1 Beta 1,3-n-acetyl-d-galactosamine transferase protein, nucleic acid encoding the same and method of examining canceration using the same
11/16/2005EP1595944A1 Hydrogel for cell separation and method of separating cells
11/16/2005EP1595941A2 Microinjectiuon device and microinjection method
11/16/2005EP1595447A1 Transgenic animal having fatty acid desaturase and method of producing the same
11/16/2005EP1594973A1 Transposon-based targeting system
11/16/2005EP1594958A2 Activation and expansion of cells
11/16/2005EP1594957A1 Progenitor cells from wharton's jelly of human umbilical cord
11/16/2005EP1594955A2 An expression cassette and vector for transient or stable expression of exogenous molecules
11/16/2005EP1594954A2 Directed genetic modifications of human stem cells
11/16/2005EP1594900A2 Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers
11/16/2005EP1594889A2 Nell peptide expression systems and bone formation activity of nell peptide
11/16/2005EP1594532A2 Methods and compositions for the inhibition of cathepsins
11/16/2005EP1594446A2 CALCIUM-SENSING RECEPTOR 2 (CaR2) AND METHODS FOR USING
11/16/2005EP1594435A2 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
11/16/2005EP1594433A2 Cancer therapy sensitizer
1 ... 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 ... 1827